Preston

This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again.

This trial is measuring small numbers of breast cancer cells that may be in the bloodstream after surgery.

This trial is looking at the targeted drug trastuzumab deruxtecan after surgery for people with oesophageal, stomach or gastro oesophageal junction cancer.

This study wants to find out more about breast cancer that has spread to the brain (secondary brain cancer).

This study is looking at gene changes in advanced solid cancers. This might help your team find a suitable early trial of a new targeted treatment for you.

This trial is looking at PET-CT guided patient led follow up.

This study is looking at using small pieces of the DNA of bowel cancer that circulate in the blood (ctDNA) to work out whether the cancer might come back.

The main study (KEYMAKER-U03) is looking at combinations of immunotherapy and targeted drugs for a type of kidney cancer called renal cell cancer.

The aim of their treatment is to control symptoms (palliative treatment).